Global Adjuvants Market Insights and Forecast to 2031

Report ID: 1451205 | Published Date: Oct 2024 | No. of Page: 96 | Base Year: 2023 | Rating: 3.7 | Webstory: Check our Web story
1 Study Coverage
    1.1 Adjuvants Product Introduction
    1.2 Market by Type
        1.2.1 Global Adjuvants Market Size by Type, 2017 VS 2021 VS 2028
        1.2.2 Adjuvant Emulsions
        1.2.3 Pathogen Components
        1.2.4 Particulate Adjuvants
        1.2.5 Combination Adjuvants
    1.3 Market by Application
        1.3.1 Global Adjuvants Market Size by Application, 2017 VS 2021 VS 2028
        1.3.2 Farming
        1.3.3 Veterinary Medicine
        1.3.4 Medicine
        1.3.5 Vaccin
        1.3.6 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Adjuvants Production
    2.1 Global Adjuvants Production Capacity (2017-2028)
    2.2 Global Adjuvants Production by Region: 2017 VS 2021 VS 2028
    2.3 Global Adjuvants Production by Region
        2.3.1 Global Adjuvants Historic Production by Region (2017-2022)
        2.3.2 Global Adjuvants Forecasted Production by Region (2023-2028)
    2.4 North America
    2.5 Europe
    2.6 China
    2.7 Japan
3 Global Adjuvants Sales in Volume & Value Estimates and Forecasts
    3.1 Global Adjuvants Sales Estimates and Forecasts 2017-2028
    3.2 Global Adjuvants Revenue Estimates and Forecasts 2017-2028
    3.3 Global Adjuvants Revenue by Region: 2017 VS 2021 VS 2028
    3.4 Global Adjuvants Sales by Region
        3.4.1 Global Adjuvants Sales by Region (2017-2022)
        3.4.2 Global Sales Adjuvants by Region (2023-2028)
    3.5 Global Adjuvants Revenue by Region
        3.5.1 Global Adjuvants Revenue by Region (2017-2022)
        3.5.2 Global Adjuvants Revenue by Region (2023-2028)
    3.6 North America
    3.7 Europe
    3.8 Asia-Pacific
    3.9 Latin America
    3.10 Middle East & Africa
4 Competition by Manufactures
    4.1 Global Adjuvants Production Capacity by Manufacturers
    4.2 Global Adjuvants Sales by Manufacturers
        4.2.1 Global Adjuvants Sales by Manufacturers (2017-2022)
        4.2.2 Global Adjuvants Sales Market Share by Manufacturers (2017-2022)
        4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Adjuvants in 2021
    4.3 Global Adjuvants Revenue by Manufacturers
        4.3.1 Global Adjuvants Revenue by Manufacturers (2017-2022)
        4.3.2 Global Adjuvants Revenue Market Share by Manufacturers (2017-2022)
        4.3.3 Global Top 10 and Top 5 Companies by Adjuvants Revenue in 2021
    4.4 Global Adjuvants Sales Price by Manufacturers
    4.5 Analysis of Competitive Landscape
        4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        4.5.2 Global Adjuvants Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        4.5.3 Global Adjuvants Manufacturers Geographical Distribution
    4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
    5.1 Global Adjuvants Sales by Type
        5.1.1 Global Adjuvants Historical Sales by Type (2017-2022)
        5.1.2 Global Adjuvants Forecasted Sales by Type (2023-2028)
        5.1.3 Global Adjuvants Sales Market Share by Type (2017-2028)
    5.2 Global Adjuvants Revenue by Type
        5.2.1 Global Adjuvants Historical Revenue by Type (2017-2022)
        5.2.2 Global Adjuvants Forecasted Revenue by Type (2023-2028)
        5.2.3 Global Adjuvants Revenue Market Share by Type (2017-2028)
    5.3 Global Adjuvants Price by Type
        5.3.1 Global Adjuvants Price by Type (2017-2022)
        5.3.2 Global Adjuvants Price Forecast by Type (2023-2028)
6 Market Size by Application
    6.1 Global Adjuvants Sales by Application
        6.1.1 Global Adjuvants Historical Sales by Application (2017-2022)
        6.1.2 Global Adjuvants Forecasted Sales by Application (2023-2028)
        6.1.3 Global Adjuvants Sales Market Share by Application (2017-2028)
    6.2 Global Adjuvants Revenue by Application
        6.2.1 Global Adjuvants Historical Revenue by Application (2017-2022)
        6.2.2 Global Adjuvants Forecasted Revenue by Application (2023-2028)
        6.2.3 Global Adjuvants Revenue Market Share by Application (2017-2028)
    6.3 Global Adjuvants Price by Application
        6.3.1 Global Adjuvants Price by Application (2017-2022)
        6.3.2 Global Adjuvants Price Forecast by Application (2023-2028)
7 North America
    7.1 North America Adjuvants Market Size by Type
        7.1.1 North America Adjuvants Sales by Type (2017-2028)
        7.1.2 North America Adjuvants Revenue by Type (2017-2028)
    7.2 North America Adjuvants Market Size by Application
        7.2.1 North America Adjuvants Sales by Application (2017-2028)
        7.2.2 North America Adjuvants Revenue by Application (2017-2028)
    7.3 North America Adjuvants Sales by Country
        7.3.1 North America Adjuvants Sales by Country (2017-2028)
        7.3.2 North America Adjuvants Revenue by Country (2017-2028)
        7.3.3 U.S.
        7.3.4 Canada
8 Europe
    8.1 Europe Adjuvants Market Size by Type
        8.1.1 Europe Adjuvants Sales by Type (2017-2028)
        8.1.2 Europe Adjuvants Revenue by Type (2017-2028)
    8.2 Europe Adjuvants Market Size by Application
        8.2.1 Europe Adjuvants Sales by Application (2017-2028)
        8.2.2 Europe Adjuvants Revenue by Application (2017-2028)
    8.3 Europe Adjuvants Sales by Country
        8.3.1 Europe Adjuvants Sales by Country (2017-2028)
        8.3.2 Europe Adjuvants Revenue by Country (2017-2028)
        8.3.3 Germany
        8.3.4 France
        8.3.5 U.K.
        8.3.6 Italy
        8.3.7 Russia
9 Asia Pacific
    9.1 Asia Pacific Adjuvants Market Size by Type
        9.1.1 Asia Pacific Adjuvants Sales by Type (2017-2028)
        9.1.2 Asia Pacific Adjuvants Revenue by Type (2017-2028)
    9.2 Asia Pacific Adjuvants Market Size by Application
        9.2.1 Asia Pacific Adjuvants Sales by Application (2017-2028)
        9.2.2 Asia Pacific Adjuvants Revenue by Application (2017-2028)
    9.3 Asia Pacific Adjuvants Sales by Region
        9.3.1 Asia Pacific Adjuvants Sales by Region (2017-2028)
        9.3.2 Asia Pacific Adjuvants Revenue by Region (2017-2028)
        9.3.3 China
        9.3.4 Japan
        9.3.5 South Korea
        9.3.6 India
        9.3.7 Australia
        9.3.8 Taiwan
        9.3.9 Indonesia
        9.3.10 Thailand
        9.3.11 Malaysia
        9.3.12 Philippines
10 Latin America
    10.1 Latin America Adjuvants Market Size by Type
        10.1.1 Latin America Adjuvants Sales by Type (2017-2028)
        10.1.2 Latin America Adjuvants Revenue by Type (2017-2028)
    10.2 Latin America Adjuvants Market Size by Application
        10.2.1 Latin America Adjuvants Sales by Application (2017-2028)
        10.2.2 Latin America Adjuvants Revenue by Application (2017-2028)
    10.3 Latin America Adjuvants Sales by Country
        10.3.1 Latin America Adjuvants Sales by Country (2017-2028)
        10.3.2 Latin America Adjuvants Revenue by Country (2017-2028)
        10.3.3 Mexico
        10.3.4 Brazil
        10.3.5 Argentina
11 Middle East and Africa
    11.1 Middle East and Africa Adjuvants Market Size by Type
        11.1.1 Middle East and Africa Adjuvants Sales by Type (2017-2028)
        11.1.2 Middle East and Africa Adjuvants Revenue by Type (2017-2028)
    11.2 Middle East and Africa Adjuvants Market Size by Application
        11.2.1 Middle East and Africa Adjuvants Sales by Application (2017-2028)
        11.2.2 Middle East and Africa Adjuvants Revenue by Application (2017-2028)
    11.3 Middle East and Africa Adjuvants Sales by Country
        11.3.1 Middle East and Africa Adjuvants Sales by Country (2017-2028)
        11.3.2 Middle East and Africa Adjuvants Revenue by Country (2017-2028)
        11.3.3 Turkey
        11.3.4 Saudi Arabia
        11.3.5 UAE
12 Corporate Profiles
    12.1 BASF
        12.1.1 BASF Corporation Information
        12.1.2 BASF Overview
        12.1.3 BASF Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
        12.1.4 BASF Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
        12.1.5 BASF Recent Developments
    12.2 Syngenta
        12.2.1 Syngenta Corporation Information
        12.2.2 Syngenta Overview
        12.2.3 Syngenta Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
        12.2.4 Syngenta Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
        12.2.5 Syngenta Recent Developments
    12.3 Bayer CropScience
        12.3.1 Bayer CropScience Corporation Information
        12.3.2 Bayer CropScience Overview
        12.3.3 Bayer CropScience Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
        12.3.4 Bayer CropScience Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
        12.3.5 Bayer CropScience Recent Developments
    12.4 Novozymes
        12.4.1 Novozymes Corporation Information
        12.4.2 Novozymes Overview
        12.4.3 Novozymes Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
        12.4.4 Novozymes Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
        12.4.5 Novozymes Recent Developments
    12.5 Koppert Biological Systems
        12.5.1 Koppert Biological Systems Corporation Information
        12.5.2 Koppert Biological Systems Overview
        12.5.3 Koppert Biological Systems Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
        12.5.4 Koppert Biological Systems Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
        12.5.5 Koppert Biological Systems Recent Developments
    12.6 Monsanto
        12.6.1 Monsanto Corporation Information
        12.6.2 Monsanto Overview
        12.6.3 Monsanto Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
        12.6.4 Monsanto Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
        12.6.5 Monsanto Recent Developments
    12.7 Biobest
        12.7.1 Biobest Corporation Information
        12.7.2 Biobest Overview
        12.7.3 Biobest Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
        12.7.4 Biobest Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
        12.7.5 Biobest Recent Developments
    12.8 Certis USA
        12.8.1 Certis USA Corporation Information
        12.8.2 Certis USA Overview
        12.8.3 Certis USA Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
        12.8.4 Certis USA Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
        12.8.5 Certis USA Recent Developments
    12.9 Andermatt Biocontrol
        12.9.1 Andermatt Biocontrol Corporation Information
        12.9.2 Andermatt Biocontrol Overview
        12.9.3 Andermatt Biocontrol Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
        12.9.4 Andermatt Biocontrol Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
        12.9.5 Andermatt Biocontrol Recent Developments
13 Industry Chain and Sales Channels Analysis
    13.1 Adjuvants Industry Chain Analysis
    13.2 Adjuvants Key Raw Materials
        13.2.1 Key Raw Materials
        13.2.2 Raw Materials Key Suppliers
    13.3 Adjuvants Production Mode & Process
    13.4 Adjuvants Sales and Marketing
        13.4.1 Adjuvants Sales Channels
        13.4.2 Adjuvants Distributors
    13.5 Adjuvants Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    14.1 Adjuvants Industry Trends
    14.2 Adjuvants Market Drivers
    14.3 Adjuvants Market Challenges
    14.4 Adjuvants Market Restraints
15 Key Finding in The Global Adjuvants Study
16 Appendix
    16.1 Research Methodology
        16.1.1 Methodology/Research Approach
        16.1.2 Data Source
    16.2 Author Details
    16.3 Disclaimer
List of Tables
    Table 1. Global Adjuvants Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Adjuvant Emulsions
    Table 3. Major Manufacturers of Pathogen Components
    Table 4. Major Manufacturers of Particulate Adjuvants
    Table 5. Major Manufacturers of Combination Adjuvants
    Table 6. Global Adjuvants Market Size Growth Rate by Application, 2017 VS 2021 2028 (US$ Million)
    Table 7. Global Adjuvants Production by Region: 2017 VS 2021 VS 2028 (K MT)
    Table 8. Global Adjuvants Production by Region (2017-2022) & (K MT)
    Table 9. Global Adjuvants Production Market Share by Region (2017-2022)
    Table 10. Global Adjuvants Production by Region (2023-2028) & (K MT)
    Table 11. Global Adjuvants Production Market Share by Region (2023-2028)
    Table 12. Global Adjuvants Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 13. Global Adjuvants Sales by Region (2017-2022) & (K MT)
    Table 14. Global Adjuvants Sales Market Share by Region (2017-2022)
    Table 15. Global Adjuvants Sales by Region (2023-2028) & (K MT)
    Table 16. Global Adjuvants Sales Market Share by Region (2023-2028)
    Table 17. Global Adjuvants Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global Adjuvants Revenue Market Share by Region (2017-2022)
    Table 19. Global Adjuvants Revenue by Region (2023-2028) & (US$ Million)
    Table 20. Global Adjuvants Revenue Market Share by Region (2023-2028)
    Table 21. Global Adjuvants Production Capacity by Manufacturers (2017-2022) & (K MT)
    Table 22. Global Adjuvants Capacity Market Share by Manufacturers (2017-2022)
    Table 23. Global Adjuvants Sales by Manufacturers (2017-2022) & (K MT)
    Table 24. Global Adjuvants Sales Market Share by Manufacturers (2017-2022)
    Table 25. Global Adjuvants Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 26. Global Adjuvants Revenue Share by Manufacturers (2017-2022)
    Table 27. Adjuvants Price by Manufacturers 2017-2022 (USD/MT)
    Table 28. Global Adjuvants Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 29. Global Adjuvants by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adjuvants as of 2021)
    Table 30. Adjuvants Manufacturing Base Distribution and Headquarters
    Table 31. Manufacturers Adjuvants Product Offered
    Table 32. Date of Manufacturers Enter into Adjuvants Market
    Table 33. Mergers & Acquisitions, Expansion Plans
    Table 34. Global Adjuvants Sales by Type (2017-2022) & (K MT)
    Table 35. Global Adjuvants Sales by Type (2023-2028) & (K MT)
    Table 36. Global Adjuvants Sales Share by Type (2017-2022)
    Table 37. Global Adjuvants Sales Share by Type (2023-2028)
    Table 38. Global Adjuvants Revenue by Type (2017-2022) & (US$ Million)
    Table 39. Global Adjuvants Revenue by Type (2023-2028) & (US$ Million)
    Table 40. Global Adjuvants Revenue Share by Type (2017-2022)
    Table 41. Global Adjuvants Revenue Share by Type (2023-2028)
    Table 42. Adjuvants Price by Type (2017-2022) & (USD/MT)
    Table 43. Global Adjuvants Price Forecast by Type (2023-2028) & (USD/MT)
    Table 44. Global Adjuvants Sales by Application (2017-2022) & (K MT)
    Table 45. Global Adjuvants Sales by Application (2023-2028) & (K MT)
    Table 46. Global Adjuvants Sales Share by Application (2017-2022)
    Table 47. Global Adjuvants Sales Share by Application (2023-2028)
    Table 48. Global Adjuvants Revenue by Application (2017-2022) & (US$ Million)
    Table 49. Global Adjuvants Revenue by Application (2023-2028) & (US$ Million)
    Table 50. Global Adjuvants Revenue Share by Application (2017-2022)
    Table 51. Global Adjuvants Revenue Share by Application (2023-2028)
    Table 52. Adjuvants Price by Application (2017-2022) & (USD/MT)
    Table 53. Global Adjuvants Price Forecast by Application (2023-2028) & (USD/MT)
    Table 54. North America Adjuvants Sales by Type (2017-2022) & (K MT)
    Table 55. North America Adjuvants Sales by Type (2023-2028) & (K MT)
    Table 56. North America Adjuvants Revenue by Type (2017-2022) & (US$ Million)
    Table 57. North America Adjuvants Revenue by Type (2023-2028) & (US$ Million)
    Table 58. North America Adjuvants Sales by Application (2017-2022) & (K MT)
    Table 59. North America Adjuvants Sales by Application (2023-2028) & (K MT)
    Table 60. North America Adjuvants Revenue by Application (2017-2022) & (US$ Million)
    Table 61. North America Adjuvants Revenue by Application (2023-2028) & (US$ Million)
    Table 62. North America Adjuvants Sales by Country (2017-2022) & (K MT)
    Table 63. North America Adjuvants Sales by Country (2023-2028) & (K MT)
    Table 64. North America Adjuvants Revenue by Country (2017-2022) & (US$ Million)
    Table 65. North America Adjuvants Revenue by Country (2023-2028) & (US$ Million)
    Table 66. Europe Adjuvants Sales by Type (2017-2022) & (K MT)
    Table 67. Europe Adjuvants Sales by Type (2023-2028) & (K MT)
    Table 68. Europe Adjuvants Revenue by Type (2017-2022) & (US$ Million)
    Table 69. Europe Adjuvants Revenue by Type (2023-2028) & (US$ Million)
    Table 70. Europe Adjuvants Sales by Application (2017-2022) & (K MT)
    Table 71. Europe Adjuvants Sales by Application (2023-2028) & (K MT)
    Table 72. Europe Adjuvants Revenue by Application (2017-2022) & (US$ Million)
    Table 73. Europe Adjuvants Revenue by Application (2023-2028) & (US$ Million)
    Table 74. Europe Adjuvants Sales by Country (2017-2022) & (K MT)
    Table 75. Europe Adjuvants Sales by Country (2023-2028) & (K MT)
    Table 76. Europe Adjuvants Revenue by Country (2017-2022) & (US$ Million)
    Table 77. Europe Adjuvants Revenue by Country (2023-2028) & (US$ Million)
    Table 78. Asia Pacific Adjuvants Sales by Type (2017-2022) & (K MT)
    Table 79. Asia Pacific Adjuvants Sales by Type (2023-2028) & (K MT)
    Table 80. Asia Pacific Adjuvants Revenue by Type (2017-2022) & (US$ Million)
    Table 81. Asia Pacific Adjuvants Revenue by Type (2023-2028) & (US$ Million)
    Table 82. Asia Pacific Adjuvants Sales by Application (2017-2022) & (K MT)
    Table 83. Asia Pacific Adjuvants Sales by Application (2023-2028) & (K MT)
    Table 84. Asia Pacific Adjuvants Revenue by Application (2017-2022) & (US$ Million)
    Table 85. Asia Pacific Adjuvants Revenue by Application (2023-2028) & (US$ Million)
    Table 86. Asia Pacific Adjuvants Sales by Region (2017-2022) & (K MT)
    Table 87. Asia Pacific Adjuvants Sales by Region (2023-2028) & (K MT)
    Table 88. Asia Pacific Adjuvants Revenue by Region (2017-2022) & (US$ Million)
    Table 89. Asia Pacific Adjuvants Revenue by Region (2023-2028) & (US$ Million)
    Table 90. Latin America Adjuvants Sales by Type (2017-2022) & (K MT)
    Table 91. Latin America Adjuvants Sales by Type (2023-2028) & (K MT)
    Table 92. Latin America Adjuvants Revenue by Type (2017-2022) & (US$ Million)
    Table 93. Latin America Adjuvants Revenue by Type (2023-2028) & (US$ Million)
    Table 94. Latin America Adjuvants Sales by Application (2017-2022) & (K MT)
    Table 95. Latin America Adjuvants Sales by Application (2023-2028) & (K MT)
    Table 96. Latin America Adjuvants Revenue by Application (2017-2022) & (US$ Million)
    Table 97. Latin America Adjuvants Revenue by Application (2023-2028) & (US$ Million)
    Table 98. Latin America Adjuvants Sales by Country (2017-2022) & (K MT)
    Table 99. Latin America Adjuvants Sales by Country (2023-2028) & (K MT)
    Table 100. Latin America Adjuvants Revenue by Country (2017-2022) & (US$ Million)
    Table 101. Latin America Adjuvants Revenue by Country (2023-2028) & (US$ Million)
    Table 102. Middle East and Africa Adjuvants Sales by Type (2017-2022) & (K MT)
    Table 103. Middle East and Africa Adjuvants Sales by Type (2023-2028) & (K MT)
    Table 104. Middle East and Africa Adjuvants Revenue by Type (2017-2022) & (US$ Million)
    Table 105. Middle East and Africa Adjuvants Revenue by Type (2023-2028) & (US$ Million)
    Table 106. Middle East and Africa Adjuvants Sales by Application (2017-2022) & (K MT)
    Table 107. Middle East and Africa Adjuvants Sales by Application (2023-2028) & (K MT)
    Table 108. Middle East and Africa Adjuvants Revenue by Application (2017-2022) & (US$ Million)
    Table 109. Middle East and Africa Adjuvants Revenue by Application (2023-2028) & (US$ Million)
    Table 110. Middle East and Africa Adjuvants Sales by Country (2017-2022) & (K MT)
    Table 111. Middle East and Africa Adjuvants Sales by Country (2023-2028) & (K MT)
    Table 112. Middle East and Africa Adjuvants Revenue by Country (2017-2022) & (US$ Million)
    Table 113. Middle East and Africa Adjuvants Revenue by Country (2023-2028) & (US$ Million)
    Table 114. BASF Corporation Information
    Table 115. BASF Description and Major Businesses
    Table 116. BASF Adjuvants Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 117. BASF Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
    Table 118. BASF Recent Development
    Table 119. Syngenta Corporation Information
    Table 120. Syngenta Description and Major Businesses
    Table 121. Syngenta Adjuvants Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 122. Syngenta Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
    Table 123. Syngenta Recent Development
    Table 124. Bayer CropScience Corporation Information
    Table 125. Bayer CropScience Description and Major Businesses
    Table 126. Bayer CropScience Adjuvants Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 127. Bayer CropScience Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
    Table 128. Bayer CropScience Recent Development
    Table 129. Novozymes Corporation Information
    Table 130. Novozymes Description and Major Businesses
    Table 131. Novozymes Adjuvants Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 132. Novozymes Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
    Table 133. Novozymes Recent Development
    Table 134. Koppert Biological Systems Corporation Information
    Table 135. Koppert Biological Systems Description and Major Businesses
    Table 136. Koppert Biological Systems Adjuvants Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 137. Koppert Biological Systems Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
    Table 138. Koppert Biological Systems Recent Development
    Table 139. Monsanto Corporation Information
    Table 140. Monsanto Description and Major Businesses
    Table 141. Monsanto Adjuvants Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 142. Monsanto Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
    Table 143. Monsanto Recent Development
    Table 144. Biobest Corporation Information
    Table 145. Biobest Description and Major Businesses
    Table 146. Biobest Adjuvants Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 147. Biobest Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
    Table 148. Biobest Recent Development
    Table 149. Certis USA Corporation Information
    Table 150. Certis USA Description and Major Businesses
    Table 151. Certis USA Adjuvants Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 152. Certis USA Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
    Table 153. Certis USA Recent Development
    Table 154. Andermatt Biocontrol Corporation Information
    Table 155. Andermatt Biocontrol Description and Major Businesses
    Table 156. Andermatt Biocontrol Adjuvants Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 157. Andermatt Biocontrol Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
    Table 158. Andermatt Biocontrol Recent Development
    Table 159. Key Raw Materials Lists
    Table 160. Raw Materials Key Suppliers Lists
    Table 161. Adjuvants Distributors List
    Table 162. Adjuvants Customers List
    Table 163. Adjuvants Market Trends
    Table 164. Adjuvants Market Drivers
    Table 165. Adjuvants Market Challenges
    Table 166. Adjuvants Market Restraints
    Table 167. Research Programs/Design for This Report
    Table 168. Key Data Information from Secondary Sources
    Table 169. Key Data Information from Primary Sources
List of Figures
    Figure 1. Adjuvants Product Picture
    Figure 2. Global Adjuvants Market Share by Type in 2021 & 2028
    Figure 3. Adjuvant Emulsions Product Picture
    Figure 4. Pathogen Components Product Picture
    Figure 5. Particulate Adjuvants Product Picture
    Figure 6. Combination Adjuvants Product Picture
    Figure 7. Global Adjuvants Market Share by Application in 2021 & 2028
    Figure 8. Farming
    Figure 9. Veterinary Medicine
    Figure 10. Medicine
    Figure 11. Vaccin
    Figure 12. Others
    Figure 13. Adjuvants Report Years Considered
    Figure 14. Global Adjuvants Capacity, Production and Utilization (2017-2028) & (K MT)
    Figure 15. Global Adjuvants Production Market Share by Region in Percentage: 2021 Versus 2028
    Figure 16. Global Adjuvants Production Market Share by Region (2017-2022)
    Figure 17. Global Adjuvants Production Market Share by Region (2023-2028)
    Figure 18. Adjuvants Production Growth Rate in North America (2017-2028) & (K MT)
    Figure 19. Adjuvants Production Growth Rate in Europe (2017-2028) & (K MT)
    Figure 20. Adjuvants Production Growth Rate in China (2017-2028) & (K MT)
    Figure 21. Adjuvants Production Growth Rate in Japan (2017-2028) & (K MT)
    Figure 22. Global Adjuvants Sales 2017-2028 (K MT)
    Figure 23. Global Adjuvants Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 24. Global Adjuvants Revenue 2017-2028 (US$ Million)
    Figure 25. Global Adjuvants Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 26. Global Adjuvants Sales Market Share by Region (2017-2022)
    Figure 27. Global Adjuvants Sales Market Share by Region (2023-2028)
    Figure 28. North America Adjuvants Sales YoY (2017-2028) & (K MT)
    Figure 29. North America Adjuvants Revenue YoY (2017-2028) & (US$ Million)
    Figure 30. Europe Adjuvants Sales YoY (2017-2028) & (K MT)
    Figure 31. Europe Adjuvants Revenue YoY (2017-2028) & (US$ Million)
    Figure 32. Asia-Pacific Adjuvants Sales YoY (2017-2028) & (K MT)
    Figure 33. Asia-Pacific Adjuvants Revenue YoY (2017-2028) & (US$ Million)
    Figure 34. Latin America Adjuvants Sales YoY (2017-2028) & (K MT)
    Figure 35. Latin America Adjuvants Revenue YoY (2017-2028) & (US$ Million)
    Figure 36. Middle East & Africa Adjuvants Sales YoY (2017-2028) & (K MT)
    Figure 37. Middle East & Africa Adjuvants Revenue YoY (2017-2028) & (US$ Million)
    Figure 38. The Adjuvants Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 39. The Top 5 and 10 Largest Manufacturers of Adjuvants in the World: Market Share by Adjuvants Revenue in 2021
    Figure 40. Adjuvants Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 41. Global Adjuvants Sales Market Share by Type (2017-2028)
    Figure 42. Global Adjuvants Revenue Market Share by Type (2017-2028)
    Figure 43. Global Adjuvants Sales Market Share by Application (2017-2028)
    Figure 44. Global Adjuvants Revenue Market Share by Application (2017-2028)
    Figure 45. North America Adjuvants Sales Market Share by Type (2017-2028)
    Figure 46. North America Adjuvants Revenue Market Share by Type (2017-2028)
    Figure 47. North America Adjuvants Sales Market Share by Application (2017-2028)
    Figure 48. North America Adjuvants Revenue Market Share by Application (2017-2028)
    Figure 49. North America Adjuvants Sales Share by Country (2017-2028)
    Figure 50. North America Adjuvants Revenue Share by Country (2017-2028)
    Figure 51. U.S. Adjuvants Revenue (2017-2028) & (US$ Million)
    Figure 52. Canada Adjuvants Revenue (2017-2028) & (US$ Million)
    Figure 53. Europe Adjuvants Sales Market Share by Type (2017-2028)
    Figure 54. Europe Adjuvants Revenue Market Share by Type (2017-2028)
    Figure 55. Europe Adjuvants Sales Market Share by Application (2017-2028)
    Figure 56. Europe Adjuvants Revenue Market Share by Application (2017-2028)
    Figure 57. Europe Adjuvants Sales Share by Country (2017-2028)
    Figure 58. Europe Adjuvants Revenue Share by Country (2017-2028)
    Figure 59. Germany Adjuvants Revenue (2017-2028) & (US$ Million)
    Figure 60. France Adjuvants Revenue (2017-2028) & (US$ Million)
    Figure 61. U.K. Adjuvants Revenue (2017-2028) & (US$ Million)
    Figure 62. Italy Adjuvants Revenue (2017-2028) & (US$ Million)
    Figure 63. Russia Adjuvants Revenue (2017-2028) & (US$ Million)
    Figure 64. Asia Pacific Adjuvants Sales Market Share by Type (2017-2028)
    Figure 65. Asia Pacific Adjuvants Revenue Market Share by Type (2017-2028)
    Figure 66. Asia Pacific Adjuvants Sales Market Share by Application (2017-2028)
    Figure 67. Asia Pacific Adjuvants Revenue Market Share by Application (2017-2028)
    Figure 68. Asia Pacific Adjuvants Sales Share by Region (2017-2028)
    Figure 69. Asia Pacific Adjuvants Revenue Share by Region (2017-2028)
    Figure 70. China Adjuvants Revenue (2017-2028) & (US$ Million)
    Figure 71. Japan Adjuvants Revenue (2017-2028) & (US$ Million)
    Figure 72. South Korea Adjuvants Revenue (2017-2028) & (US$ Million)
    Figure 73. India Adjuvants Revenue (2017-2028) & (US$ Million)
    Figure 74. Australia Adjuvants Revenue (2017-2028) & (US$ Million)
    Figure 75. Taiwan Adjuvants Revenue (2017-2028) & (US$ Million)
    Figure 76. Indonesia Adjuvants Revenue (2017-2028) & (US$ Million)
    Figure 77. Thailand Adjuvants Revenue (2017-2028) & (US$ Million)
    Figure 78. Malaysia Adjuvants Revenue (2017-2028) & (US$ Million)
    Figure 79. Philippines Adjuvants Revenue (2017-2028) & (US$ Million)
    Figure 80. Latin America Adjuvants Sales Market Share by Type (2017-2028)
    Figure 81. Latin America Adjuvants Revenue Market Share by Type (2017-2028)
    Figure 82. Latin America Adjuvants Sales Market Share by Application (2017-2028)
    Figure 83. Latin America Adjuvants Revenue Market Share by Application (2017-2028)
    Figure 84. Latin America Adjuvants Sales Share by Country (2017-2028)
    Figure 85. Latin America Adjuvants Revenue Share by Country (2017-2028)
    Figure 86. Mexico Adjuvants Revenue (2017-2028) & (US$ Million)
    Figure 87. Brazil Adjuvants Revenue (2017-2028) & (US$ Million)
    Figure 88. Argentina Adjuvants Revenue (2017-2028) & (US$ Million)
    Figure 89. Middle East and Africa Adjuvants Sales Market Share by Type (2017-2028)
    Figure 90. Middle East and Africa Adjuvants Revenue Market Share by Type (2017-2028)
    Figure 91. Middle East and Africa Adjuvants Sales Market Share by Application (2017-2028)
    Figure 92. Middle East and Africa Adjuvants Revenue Market Share by Application (2017-2028)
    Figure 93. Middle East and Africa Adjuvants Sales Share by Country (2017-2028)
    Figure 94. Middle East and Africa Adjuvants Revenue Share by Country (2017-2028)
    Figure 95. Turkey Adjuvants Revenue (2017-2028) & (US$ Million)
    Figure 96. Saudi Arabia Adjuvants Revenue (2017-2028) & (US$ Million)
    Figure 97. UAE Adjuvants Revenue (2017-2028) & (US$ Million)
    Figure 98. Adjuvants Value Chain
    Figure 99. Adjuvants Production Process
    Figure 100. Channels of Distribution
    Figure 101. Distributors Profiles
    Figure 102. Bottom-up and Top-down Approaches for This Report
    Figure 103. Data Triangulation
    Figure 104. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
BASF
Syngenta
Bayer CropScience
Novozymes
Koppert Biological Systems
Monsanto
Biobest
Certis USA
Andermatt Biocontrol
Frequently Asked Questions
Adjuvants report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Adjuvants report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Adjuvants report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Advanced Batteries

Advanced Batteries market is segmented by Type and by Application. Players, stakeholders, and oth ... Read More

Advanced Functional

Advanced Functional market is segmented by Type and by Application. Players, stakeholders, and ot ... Read More

AFP Testing

AFP Testing market is segmented by players, region (country), by Type and by Application. Players ... Read More